Home Stock Earnings G (Genpact Limited) may reap gains as insiders became active recently

G (Genpact Limited) may reap gains as insiders became active recently

0
G (Genpact Limited) may reap gains as insiders became active recently

Genpact Limited’s recent filing unveils that its President and CEO Tyagarajan N. V. unloaded Company’s shares for reported $2.33 million on Nov 03. In the deal valued at $46.51 per share,50,000 shares were sold. As a result of this transaction, Tyagarajan N. V. now holds 644,377 shares worth roughly $ 29.84 million.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


Then, Tyagarajan N. V. sold 50,000 shares, generating $2,412,023 in total proceeds. Upon selling the shares at $48.24, the President and CEO now owns 644,377 shares.

Before that, Tyagarajan N. V. sold 50,000 shares. Genpact Limited shares valued at $2,422,865 were divested by the President and CEO at a price of $48.46 per share. As a result of the transaction, Tyagarajan N. V. now holds 644,377 shares, worth roughly $29.84 million.

Cowen downgraded its Genpact Limited [G] rating to a Market perform from a an Outperform in a research note published on Friday, February 14, 2022; the price target was decreased to $51 from $57. PT values the company’s stock at a premium of 9.2 to its Friday closing price. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late January with a ‘”a Hold”‘ rating. Needham also remained covering G and reiterated its “Buy” recommendation on November 03, 2020. Needham maintained its rating on May 12, 2020. It rated G as “a Buy”.

Price Performance Review of G

On Friday, Genpact Limited [NYSE:G] saw its stock jump 0.15% to $46.31. On the same session, the stock had its day’s lowest price of $45.76, but rose to a high of $47.04. Over the last five days, the stock has lost -4.55%. Genpact Limited shares have fallen nearly -12.75% since the year began. Nevertheless, the stocks have fallen -8.46% over the past one year. While a 52-week high of $54.03 was reached on 01/04/22, a 52-week low of $37.68 was recorded on 05/05/22. SMA at 50 days reached $45.76, while 200 days put it at $44.60. A total of 0.88 million shares were traded, compared to the trading of 1.18 million shares in the previous session.

Levels Of Support And Resistance For G Stock

The 24-hour chart illustrates a support level at 45.70, which if violated will result in even more drops to 45.09. On the upside, there is a resistance level at 46.98. A further resistance level may holdings at 47.65. The Relative Strength Index (RSI) on the 14-day chart is 49.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.62%. Stochastics %K at 50.00% indicates the stock is a holding.

How much short interest is there in Genpact Limited?

A steep rise in short interest was recorded in Genpact Limited stocks on Jul 14, 2022, dropping by -0.66 million shares to a total of 1.77 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 2.43 million shares. There was a decline of -37.29%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.24% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.78.

Genpact Limited [G] – Who Are The Largest Shareholders?

In filings from Wellington Management Co. LLP, it is revealed that the company now owns 17,069,586 shares, or roughly 9.30% of the outstanding G shares. In other words, the investor’s shares have fallen by -2,377,943 from its previous 13-F filing of 19447529.0. Additionally, Fidelity Management & Research Co decreased -17.75% of its stake after which the total value it holdings stand at $721,623,734, while The Vanguard Group, Inc. added 1.07% of its stake to hold $711.77 million in the firm. Over the last quarter, BlackRock Fund Advisors sold -473,324 shares of Genpact Limited, while Victory Capital Management, Inc. sold 347,909 shares. At present, Brown Advisory LLC is holding 5,661,542 shares valued at $247.81 million. AllianceBernstein LP owned 5,197,840 shares of the company at the time of its most recent 13F filing, worth $227.51 million.

According to FactSet, Genpact Limited’s share price will average $52.30 in the next year, based on opinions of analysts polled by the firm. This is up nearly 17.86 percent from its previous closing price of $46.24. Analysts expect Genpact Limited stock to reach the higher price of $57.00, while the lowest price estimate is $45.00. However, 12 analysts have rated G stock as an Overweight in their predictions for 2022.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]